Document is current
Any future updates will be listed below
-
Authors
Hermelo, Ismaïl
Virtanen, Tuomo
Salonen, Iida
Nätkin, Reetta
Keitaanniemi, Sofia
Tiihonen, Aliisa M.
Lehtipuro, Suvi
Kummola, Laura
Raulamo, Ella
Nordfors, Kristiina
Haapasalo, Hannu
Rauhala, Minna
Kesseli, Juha
Nykter, Matti
Haapasalo, Joonas
Rautajoki, Kirsi
-
Funding
Funding for this research was provided by:
Tampere University Faculty of Medicine and Health Technology
Finnish Brain Foundation-Neurology Fund
Research Council of Finland (#312043, #333545)
Cancer Foundation Finland
Sigrid Jusélius Foundation
Finnish Cancer Institute
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital
Emil Aaltonen Foundation
Tampere University
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 3 December 2024
First Online: 3 January 2025
Declarations
:
: The authors declare no competing interests.
: The study was performed in accordance with the principles of the Declaration of Helsinki. This prospective study was reviewed and approved by The Regional Ethics Committee of Pirkanmaa Hospital District, currently named as the Ethics Committee of the Wellbeing Services County of Pirkanmaa, with the reference of the approval number R14024.
: All patients provided informed consent to the use of tumor material for the applications used in this study.
: All the participants of this study provided informed consent for publication of their data according to the legislation and good practice.
